Stock Quote

Anti-Infective Drugs Market Research Report 2020 Growth, Recent Trends and Forecast to 2030; Gilead Sciences, Inc. (NASDAQ:GILD); Merck & Co. Inc.(NYSE:MRK)

By: X herald

MarketInsightsReport has published a report titled Global Anti-Infective Drugs Market research report 2020 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.

The global anti-infective drugs market is expected to grow from $106.5 billion in 2019 to $139.3 billion in 2020 at a compound annual growth rate (CAGR) of 30.8%. The significant growth is mainly due to the COVID-19 outbreak and the huge demand for anti-viral and antibiotic drugs. Although other anti-infective drugs like antifungals have seen a dip in sales, the enormous demand for antiviral drugs and antibiotic drugs such as Azithromycin, Chloroquine, Acyclovir, and Ribavirin among others have contributed to the overall market growth of anti-infective drugs. The market is then expected to recover and grow at a CAGR of 6% from 2021 and reach $159.6 billion in 2023.

Top Companies in the global Anti-Infective Drugs Market are
Gilead Sciences, Inc. (NASDAQ:GILD); Merck & Co. Inc.(NYSE:MRK); GlaxosmithKline; Bristol-Myers Squibb Company; Johnson & Johnson(NYSE:JNJ); and Others.

Click here to get the latest sample PDF copy of updated research 2020 before purchase
https://www.marketinsightsreports.com/reports/06022059403/anti-infective-drugs-global-market-report-2020-30-covid-19-implications-and-growth-including-1-by-type-antibiotics-antivirals-antifungals-others-anthelminthic-antiprotozoal-2-by-distribution-channel-hospital-pharmacies-retail-pharmacies-drug-stores-others-3-by-route-of-administration-oral-parenteral-others-4-by-drug-classification-branded-drugs-generic-drugs-5-by-mode-of-purchase-prescription-based-drugs-over-the-counter-drugs-covering-gilead-merck-co-glaxosmithkline-bristol-myers-squibb-company-johnson-johnson/inquiry?mode=72&source=XH

North America was the largest region in the global anti-infective drugs market, accounting for 50% of the market in 2019. Asia Pacific was the second largest region accounting for 20% of the global anti-infective drugs market. Africa was the smallest region in the global anti-infective drugs market.
Companies in this market are active with multiple strategic collaborations and agreements. Top companies in the anti-infective drug market are strategically partnering and collaborating with other companies to broaden their products and services. For instance, in May 2015, Janssen Pharmaceuticals Inc., subsidiary of Johnson & Johnson has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals Inc. to develop and commercialize one or more of Achillion’s lead hepatitis C virus (HCV) assets which include ACH-3102, ACH-3422 and sovaprevir . Also in December 2017, Evotec AG was in a strategic alliance with Forge Therapeutics Inc. to advance its novel Gram-negative antibiotic programme targeting ‘LpxC’ for the treatment of bacterial infections. Chimerix and ContraVir Pharmaceuticals also entered into a strategic collaboration for antiviral drug candidate CMX157.
The anti-infective drugs market consists of sales of anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce anti-infective drugs to treat microbial infections. This industry includes establishments that produce antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti- helminthic drugs to kill internal parasites and antiprotozoal agents.

Markets Covered:
1) By Type: Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal)
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Browse full report description with TOC
https://www.marketinsightsreports.com/reports/06022059403/anti-infective-drugs-global-market-report-2020-30-covid-19-implications-and-growth-including-1-by-type-antibiotics-antivirals-antifungals-others-anthelminthic-antiprotozoal-2-by-distribution-channel-hospital-pharmacies-retail-pharmacies-drug-stores-others-3-by-route-of-administration-oral-parenteral-others-4-by-drug-classification-branded-drugs-generic-drugs-5-by-mode-of-purchase-prescription-based-drugs-over-the-counter-drugs-covering-gilead-merck-co-glaxosmithkline-bristol-myers-squibb-company-johnson-johnson?mode=72&source=XH

Regions covered By Anti-Infective Drugs Market Report 2020 To 2030 are
North America (The United States, Canada, and Mexico), Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Central & South America (Brazil, and Rest of South America), and Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other)

Effect of the Anti-Infective Drugs market report is
– A comprehensive evaluation of all opportunities and risks in the market.
– Anti-Infective Drugs market current developments and significant occasions.
– A deep study of business techniques for the development of the market-driving players.
– Conclusive study about the improvement plot of the market for approaching years.
– Top to the bottom approach of market-express drivers, targets, and major littler scale markets.
– Favorable impressions inside imperative mechanical and publicize the latest examples striking the market.

Contact Us
Irfan Tamboli (Sales Manager) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.